Understanding Hereditary Spastic Paraplegias and Related Disorders
Official title: Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders
Run by University Hospital Tuebingen · NCT03981276 · Data updated 2026-11-12
This study is trying to learn more about Hereditary Spastic Paraplegias and related disorders by following patients over time and looking at their symptoms, genetics, and potential treatments.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | University Hospital Tuebingen Academic / other |
| Locations | 13 sites (Innsbruck and 12 other locations) |
| Status | Recruiting |
| Started | October 14, 2019 |
| Main results expected | August 2039 |
| Study ends | August 2041 |
| Registry record updated | May 19, 2021 |
| Trial ID | NCT03981276 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a clinical or genetic diagnosis of HSP or related disorders, as well as unaffected family members or healthy controls.
✕Probably not a fit
Patients with evidence of other neurodegenerative diseases or movement disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the clinical spectrum and natural progression of Hereditary Spastic Paraplegias (HSP) and related disorders through a multicenter natural history approach. Participants will undergo annual standardized clinical examinations and have the option to donate biosamples for biomarker analysis. The study will also investigate genetic etiology and molecular mechanisms, utilizing next-generation sequencing for those without a genetic diagnosis. Data will be collected in a clinical database to aid in diagnosis and therapy development.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and treatment options for patients with Hereditary Spastic Paraplegia.
How similar studies have gone: Other studies focusing on the natural history and biomarkers of neurodegenerative diseases have shown promise, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria:
* One of the following:
1. Primary participant: Clinical or genetic diagnosis of HSP or a related disorder
2. Secondary participant: Unaffected family member (1st or 2nd degree relative) of primary participant (with the above-mentioned restrictions for special populations) able to give informed consent
3. Unrelated healthy control able to give informed consent
AND
* Written informed consent
AND
\- Participants are willing and able to comply with study procedures
Exclusion criteria:
* Missing informed consent of primary or secondary participant/ healthy control/ legal representatives
* For controls: evidence of a neurodegenerative disease or movement disorders; inability to give informed consent
Where it's running
-
University Innsbruck
Innsbruck, Austria Recruiting -
German Center for Neurodegenerative Diseases (DZNE) Bonn
Bonn, Germany Recruiting -
University of Erlangen
Erlangen, Germany Recruiting -
University Medicine Essen
Essen, Germany Recruiting -
University Göttingen
Göttingen, Germany Recruiting -
German Center for Neurogedenerative Diseases (DZNE) Magdeburg
Magdeburg, Germany Recruiting
Show 7 more locations
-
German Center for Neurodegenerative Diseases (DZNE) München
München, Germany Recruiting -
University of Tübingen and German Center for Neurodegenerative Diseases (DZNE) Tübingen
Tübingen, Germany Recruiting -
University Heidelberg
Heidelberg, Germany Not yet recruiting -
University of Lübeck
Lübeck, Germany Not yet recruiting -
University of Regensburg
Regensburg, Germany Not yet recruiting -
German Center for Neurodegenerative Diseases (DZNE) Rostock
Rostock, Germany Not yet recruiting -
IRCCS Medea Scientific Institute, Conegliano-PIeve di Soligo Research Centre
Pieve di Soligo, Italy Not yet recruiting
Study contacts
- Principal investigator: Rebecca Schüle, PD Dr. — University Hospital Tuebingen
- Study coordinator: Rebecca Schüle, PD Dr.
- Email: rebecca.schuele-freyer@uni-tuebingen.de
- Phone: +49 7071 29
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rare Disease Registry for Movement Disorders in Southern Anhui
This project is creating a registry to collect information from adults with motor neuron diseases, spinocerebellar ataxias, hereditary muscular dystrophy, or hereditary spastic paraplegia in Southern Anhui.
-
TreatHSP/SPAX: An adaptive natural history platform for SPAX diseases
This study tests a shared, long-term framework to track how SPAX diseases progress and to develop useful patient-centered outcome measures and biomarkers.
-
Noninvasive spinal stimulation to improve walking in hereditary spastic paraplegia
This trial will test whether noninvasive transcutaneous spinal cord stimulation can improve walking and reduce muscle stiffness in adults with hereditary spastic paraplegia.
-
Wearable monitoring of walking and arm movement in adults with neuromuscular or metabolic movement disorders
This project uses a wrist/ankle wearable to continuously monitor walking and upper-limb movement in ambulant adults with neuromuscular diseases or obesity to see if digital measures like stride speed track real-life motor function.
-
Evaluating surgical treatment for foot deformities in hereditary spastic paraplegia
This study is testing how well surgery can help people with hereditary spastic paraplegia and foot deformities feel and function better over two years.
-
Exploring intrathecal baclofen treatment for hereditary spastic paraplegia
This study is testing if a special pump that delivers baclofen directly into the spine can help people with hereditary spastic paraplegia improve their movement and quality of life better than taking the medication by mouth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.